Aram Hezel, MD
Project 1 Clinical Trials Co-Leader
Chief, Department of Medicine, Hematology/Oncology at University of Rochester; John and Ethel Heselden Professorship, Department of Medicine, University of Rochester
Dr. Hezel’s research focuses on the biology, genetics and therapeutic development in pancreatic ductal adenocarcinoma. Key interests include understanding which potentially targetable signaling pathways are important in fully established tumors as well as how to best disrupt these pathways. The refinement and development of improved preclinical models for evaluating therapies are also of primary concern.